<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Adipocyte fatty acid-binding protein (A-FABP) is abundantly expressed in adipocytes and plays a role in <z:chebi fb="105" ids="17234">glucose</z:chebi> homeostasis in experimental animals </plain></SENT>
<SENT sid="1" pm="."><plain>We have previously shown that circulating A-FABP levels are associated with the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, which confers an increased risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Here we investigated whether serum A-FABP levels could predict the development of <z:mp ids='MP_0002055'>diabetes</z:mp> in a 10-year prospective study </plain></SENT>
<SENT sid="3" pm="."><plain>RESEARCH DESIGN AND METHODS: Baseline serum A-FABP levels were measured with an enzyme-linked immunosorbent assay in 544 nondiabetic subjects, recruited from the Hong Kong <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">Cardiovascular Risk Factor</z:e> Prevalence Study cohort, who were followed prospectively to assess the development of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>The role of A-FABP in predicting the development of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> over 10 years was investigated using Cox regression analysis </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: At baseline, serum sex-adjusted A-FABP levels were higher in subjects with <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT) or impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> (IFG) (P &lt; 0.00001 versus <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance) and correlated positively with adverse cardiometabolic risk factors </plain></SENT>
<SENT sid="6" pm="."><plain>Over 10 years, 96 subjects had developed type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>High baseline A-FABP was predictive of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, independent of <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, or glycemic indexes (relative risk [RR] 2.25 [95% CI 1.40-3.65]; P = 0.001; above versus below sex-specific median) </plain></SENT>
<SENT sid="8" pm="."><plain>High A-FABP levels remained an independent predictor of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in the high-risk IGT/IFG subgroup (adjusted RR 1.87 [1.12-3.15]; P = 0.018) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Serum A-FABP was associated with <z:chebi fb="105" ids="17234">glucose</z:chebi> dysregulation and predicted the development of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in a Chinese cohort </plain></SENT>
</text></document>